DE SILVA RAJIV
Insider CIK 1453140 · ENDP President & CEO, Director · VERO Officer, Director · ENDP President & CEO, Director · AMAG Director · VRX President and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERO Venus Concept Inc. | P Buy | 2022-11-18 | 2022-11-22 | 1,250,000 | $0.20 | $250.0K | 1,250,000 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2022-10-02 | 2022-10-04 | 3,300,000 | — | $0 | 3,300,000 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2016-03-21 | 2016-03-22 | 61,636 | — | $0 | 319,794 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2016-03-21 | 2016-03-22 | 28,099 | $29.78 | $836.8K | 291,695 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2016-03-21 | 2016-03-22 | 82,182 | — | $0 | 304,402 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2016-03-18 | 2016-03-22 | 6,244 | $30.43 | $190.0K | 258,158 | SEC↗ |
| ENDP Endo International plc | P Buy | 2016-03-07 | 2016-03-07 | 2,250 | $44.50 | $100.1K | 250,705 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2016-03-02 | 2016-03-04 | 123,273 | — | $0 | 304,653 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2016-03-02 | 2016-03-04 | 56,198 | $43.06 | $2.42M | 248,455 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2016-03-02 | 2016-03-04 | 82,182 | — | $0 | 386,584 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2016-02-23 | 2016-02-25 | 167,897 | — | $0 | 167,897 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-02-23 | 2016-02-25 | 149,342 | — | $0 | 468,766 | SEC↗ |
| ENDP Endo International plc | P Buy | 2015-11-11 | 2015-11-12 | 9,006 | $55.52 | $500.0K | 181,380 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2015-02-24 | 2015-02-26 | 85,245 | — | $0 | 85,245 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-02-24 | 2015-02-26 | 69,290 | — | $0 | 319,424 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2014-12-31 | 2015-01-05 | 6,244 | $72.90 | $455.2K | 172,374 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2014-09-02 | 2014-09-15 | 103,284 | — | $0 | 103,284 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-09-02 | 2014-09-15 | 85,770 | — | $0 | 250,134 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer deriv | 2014-02-28 | 2014-03-03 | 135,899 | — | $0 | 0 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2014-02-28 | 2014-03-04 | 135,899 | — | $0 | 135,899 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 82,182 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 164,921 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 63,315 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 27,394 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 82,182 | — | $0 | 0 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 164,921 | — | $0 | 164,921 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 82,182 | — | $0 | 82,182 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 63,315 | — | $0 | 63,315 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 27,394 | — | $0 | 27,394 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 82,182 | — | $0 | 82,182 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | F Tax w/h | 2013-12-31 | 2014-01-02 | 7,179 | $67.29 | $483.1K | 164,921 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-01-05 | 2013-01-08 | 5,450 | — | $0 | 259,767 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-11-08 | 2012-11-09 | 76,344 | — | $0 | 96,136 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-11-08 | 2012-11-09 | 76,344 | $25.42 | $1.94M | 341,561 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2012-11-08 | 2012-11-09 | 76,344 | $54.04 | $4.13M | 265,217 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-11-06 | 2012-11-08 | 101,479 | — | $0 | 101,480 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-11-06 | 2012-11-08 | 19,790 | — | $0 | 172,480 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-11-06 | 2012-11-08 | 27,110 | — | $0 | 13,556 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-11-06 | 2012-11-08 | 72,315 | — | $0 | 72,316 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-11-06 | 2012-11-08 | 101,479 | $13.24 | $1.34M | 466,121 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2012-11-06 | 2012-11-08 | 121,054 | $54.05 | $6.54M | 364,857 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-11-06 | 2012-11-08 | 19,790 | $25.42 | $503.1K | 485,911 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2012-11-06 | 2012-11-08 | 99,640 | $54.78 | $5.46M | 265,217 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-11-06 | 2012-11-08 | 72,315 | $7.81 | $564.8K | 364,642 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-11-06 | 2012-11-08 | 27,110 | $7.81 | $211.7K | 292,327 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2012-11-06 | 2012-11-08 | 2 | — | $0 | 265,217 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-24 | 2012-10-26 | 955 | — | $0 | 265,219 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-09-26 | 2012-09-28 | 87,952 | — | $0 | 87,952 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-09-26 | 2012-09-28 | 40,766 | — | $0 | 266,174 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-09-26 | 2012-09-28 | 87,952 | — | $0 | 306,940 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-07-25 | 2012-07-27 | 2,293 | — | $0 | 218,988 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-05-24 | 2012-05-29 | 14,822 | — | $0 | 14,822 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-05-23 | 2012-05-25 | 2,300 | — | $0 | 2,300 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-05-23 | 2012-05-25 | 3,800 | — | $0 | 3,800 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-02-06 | 2012-02-07 | 950 | — | $0 | 950 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-02-06 | 2012-02-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-02-06 | 2012-02-07 | 475 | — | $0 | 475 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-01-05 | 2012-01-09 | 12,364 | — | $0 | 235,574 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2011-09-23 | 2012-02-22 | 6,957 | — | $0 | 221,281 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2011-09-19 | 2012-02-22 | 7,336 | — | $0 | 228,238 | SEC↗ |